Capacity building to support the uptake of biosimilars in a multistakeholder approach

Biosimilar medicines have a similar efficacy and safety compared with their reference medicines and hold the potential to achieve significant savings for health systems and improve access to medicines for patients. Still, barriers remain and, to a certain extent, impede their successful entry into the market and uptake by health systems.

This call for tenders aims to support national authorities in implementing policies and practices that improve biosimilar competition to contribute to the accessibility, affordability and availability of medicines for patients in the EU.

Estimated budget: €1 500 000

Read more and apply on the Funding & Tenders portal.